Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead, Merck Spar Over Hepatitis C $1,000-Pill Royalties
Gilead, Merck Spar Over Hepatitis C $1,000-Pill Royalties
Gilead, Merck Spar Over Hepatitis C $1,000-Pill Royalties
Submitted by
admin
on March 7, 2016 - 9:58pm
Source:
Bloomberg
News Tags:
Gilead Sciences
Merck
hepatitis C
Sovaldi
Harvoni
Headline:
Gilead, Merck Spar Over Hepatitis C $1,000-Pill Royalties
Do Not Allow Advertisers to Use My Personal information
